Expression of E-cadherin and β-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer

Hepato-Gastroenterology

Volumn 53, Issue 67, 2006, Pages 28-32

  Park, Sunhoo ^a,b   Kim, Sun Whe ^a   Lee, Byung Lan ^a   Jung, Eun Ji ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

Adenocarcinoma; Cadherin; Immunohistochemistry; Precancerous conditions; Vater's ampulla

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADENOMA; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; VATER PAPILLA CARCINOMA;

ADENOMA; AMPULLA OF VATER; BETA CATENIN; CADHERINS; CARCINOMA; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; MALE; PRECANCEROUS CONDITIONS;

EID: 33344470234     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hayes DH, Bolton JS, Willis GW, Bowen JC: Carcinoma of the ampulla of Vater. Ann Surg 1987; 206:572-577,
2. Yamaguchi K, Enjoji M: Carcinoma of the ampulla of Vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59:506-515.
3. Yamauchi H, Nitta A, Namiki T: Carcinoma of the papilla of Vater accompanied by non-invasive adenomatous component (NAC). Tohoku J Exp Med 1993; 170:147-156.
4. Baczako K, Buchler M, Beger HG, Kirkpatrick CJ, Haferkamp O: Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol 1985; 16:305-310.
5. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251:1451-1455.
6. Ozawa M, Kemler R: Molecular organization of the uvomorulin-catenin complex. J Cell Biol 1992; 116:989-996.
7. Pignatelli M, Liu D, Nasim MM, Stamp GW, Hirano S, Takeichi M: Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer 1992; 66:629-634.
8. Behrens J, Mareel MM, Van Roy FM, Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108:2435-2447.
9. Pignatelli M: E-cadherin: a biological marker of tumour differentiation. J Pathol 1993; 171:81-82.
10. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, et al: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53:1696-1701.
11. Nigam AK, Savage FJ, Boulos PB, Stamp GW, Liu D, Pignatelli M: Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993; 68:507-514.
12. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54:3929-3933.
13. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G, Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994; 174:243-248.
14. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51:6328-6337.
15. Valizadeh A, Karayiannakis AJ, el-Hariry I, Kmiot W, Pignatelli M: Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol 1997; 150:1977-1984.
16. Ilyas M, Tomlinson IP: The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 1997; 182:128-137.
17. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler K W, Vogelstein B, Clevere H: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275:1784-1787.
18. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S: Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 1996; 56:2213-2217.
19. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P: Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995; 92:3046-3050.
20. Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P: Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 1997; 57:4624-4630.
21. Nakamura Y: Cleaning up on beta-catenin. Nat Med 1997; 3:499-500.
22. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P: Association of the APC gene product with beta-catenin. Science 1993; 262:1731-1734.
23. American Joint Committee on Cancer. Ampulla of Vater. In AJCC Cancer Staging Manual, 6th Edition. New York: Springer, 2000; pp. 151-156.
24. Park SH, Kim YI, Park YH, Kim SW, Kim KW, Kim YT, Kim WH: Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54-59.
25. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-532.
26. Fleming S: C.L. Oakley Lecture (1991). Cell adhesion and epithelial differentiation. J Pathol 1991; 164:95-100.
27. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I: E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53:1690-1695.
28. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993; 53:3241-3245.
29. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH: Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95:108-113.
30. Gumbiner BM: Signal transduction of beta-catenin. Curr Opin Cell Biol 1995; 7:634-640.